NCT05667272招募中不适用
A Study on the Occurrence Time of Clinically Relevant Postoperative Pancreatic Fistula of Grade-B After Pancreatoduodenectomy
Changzhou Second People's Hospital affiliated with Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 216 人开始时间: 2023年2月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 216
- 试验地点
- 1
- 主要终点
- Postoperative complications
研究概览
简要总结
To confirm the time point of CR-POPF of grade-B that patients with biochemical leak after PD or LPD turned into.
详细描述
- To confirm the time point of CR-POPF of grade-B that patients with biochemical leak after PD or LPD turned into.
- Establishment of risk assessment model for Grade B fistula.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients underwent Pancreatoduodenectomy (PD) or Laparoscopic pancreatoduodenectomy (LPD) surgery.
- •Surgery performed by the same surgical team.
排除标准
- •PD or LPD combined with another organ resection.
- •PD or LPD performed due to trauma.
- •PD or LPD for emergency treatment, such as the rupture and bleeding of tumor.
- •Palliative resection.
- •Patients with severe organ dysfunction before surgery.
- •Patients treated with preoperative neoadjuvant chemotherapy or other treatments (Radiotherapy, targeted immunotherapy, etc.).
- •Patients with missing data for clinical or radiographic variables.
结局指标
主要结局
Postoperative complications
时间窗: up to postoperative 30 days
Postoperative complications for each patient
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Prolonged Cardiopulmonary Bypass Time as a Predictive Factor for AGI After Heart Valve ReplacementHeart Valve DiseasesNCT05498935Hepatopancreatobiliary Surgery Institute of Gansu Province1,070
已完成
不适用
Impact of Timing of PD Assessments on Measures of Platelet Reactivity in Patients Undergoing PCI Treated With CangrelorCoronary Artery DiseaseNCT04668495University of Florida17
已完成
1 期
A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood Following Dosing By Oral Inhalation From Dry Powder Inhalers.HealthyNCT00862667Pfizer36
已完成
1 期
A Study to Estimate the Time Course of PF-00241939 Concentration in the Blood Following Dosing by Oral Inhalation From Dry Powder InhalersPharmacokineticsNCT00867282Pfizer36
已完成
1 期
A Study To Estimate The Time Course Of PF-00241939 Concentration In The Blood After Dosing With Oral Inhalation From Dry Powder InhalersPharmacokineticsNCT01181700Pfizer42